ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Probing the Potential of Defense Response-Associated Genes for Predicting the Progression, Prognosis, and Immune Microenvironment of Osteosarcoma

Huang, Liangkun; Sun, Fei; Liu, Zilin; Jin, Wenyi; Zhang, Yubiao; Chen, Junwen; Zhong, Changheng; Liang, Wanting; Peng, Hao*武汉大学
Cancers2023-4DOI: 10.3390/cancers15082405
6被引4阅读
引用收藏
分享

摘要

Simple Summary Osteosarcoma (OS) is the most common primary orthopedic malignancy and typically affects children and young adults. Its lesions often metastasize to distant sites in the body, such as the lungs. Metastatic OS frequently recurs and has a poor prognosis. Our main objective of this study is to provide new insights into the clinical management of patients with osteosarcoma and to explore the risk factors affecting osteosarcoma metastasis. We established a biological marker consisting of three genes from the perspective of defense response for the first time to predict the prognosis of osteosarcoma and to discover new treatment methods. Our findings have implications for both the clinical management and future research of osteosarcoma. Background: The defense response is a type of self-protective response of the body that protects it from damage by pathogenic factors. Although these reactions make important contributions to the occurrence and development of tumors, the role they play in osteosarcoma (OS), particularly in the immune microenvironment, remains unpredictable. Methods: This study included the clinical information and transcriptomic data of 84 osteosarcoma samples and the microarray data of 12 mesenchymal stem cell samples and 84 osteosarcoma samples. We obtained 129 differentially expressed genes related to the defense response (DRGs) by taking the intersection of differentially expressed genes with genes involved in the defense response pathway, and prognostic genes were screened using univariate Cox regression. Least absolute shrinkage and selection operator (LASSO) penalized Cox regression and multivariate Cox regression were then used to establish a DRG prognostic signature (DGPS) via the stepwise method. DGPS performance was examined using independent prognostic analysis, survival curves, and receiver operating characteristic (ROC) curves. In addition, the molecular and immune mechanisms of adverse prognosis in high-risk populations identified by DGPS were elucidated. The results were well verified by experiments. Result: BNIP3, PTGIS, and ZYX were identified as the most important DRGs for OS progression (hazard ratios of 2.044, 1.485, and 0.189, respectively). DGPS demonstrated outstanding performance in the prediction of OS prognosis (area under the curve (AUC) values of 0.842 and 0.787 in the training and test sets, respectively, adj-p < 0.05 in the survival curve). DGPS also performed better than a recent clinical prognostic approach with an AUC value of only 0.674 [metastasis], which was certified in the subsequent experimental results. These three genes regulate several key biological processes, including immune receptor activity and T cell activation, and they also reduce the infiltration of some immune cells, such as B cells, CD8+ T cells, and macrophages. Encouragingly, we found that DGPS was associated with sensitivity to chemotherapeutic drugs including JNK Inhibitor VIII, TGX221, MP470, and SB52334. Finally, we verified the effect of BNIP3 on apoptosis, proliferation, and migration of osteosarcoma cells through experiments. Conclusions: This study elucidated the role and mechanism of BNIP3, PTGIS, and ZYX in OS progression and was well verified by the experimental results, enabling reliable prognostic means and treatment strategies to be proposed for OS patients.

学科与关键词

关键词
defense responseosteosarcomaprognosismetastasisimmunetherapy
相关
加载中…
  • Identification and Analysis of Three Hub Prognostic Genes Related to Osteosarcoma Metastasis
    Tan, Jianye; Liang, Haofeng; Yang, Bingsheng; Zhu, Shuang; Wu, Guofeng; Li, Lutao; Liu, Zhengwei; Li, Lin; Qi, Weizhong; Li, Sijing; Lin, LijunJournal of Oncology, 2021, 2021: 6646459.被引 9
  • Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma
    Yang, Bingsheng; Su, Zexin; Chen, Guoli; Zeng, Zhirui; Tan, Jianye; Wu, Guofeng; Zhu, Shuang*; Lin, Lijun*Oncology Letters, 2021, 21(3): 180.被引 20
  • Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature
    Zhong, Yujian; Zhang, Yubiao; Wei, Sixing; Chen, Junwen; Zhong, Changheng; Cai, Wenxiang; Jin, Wenyi*; Peng, Hao*Frontiers in Endocrinology, 2022, 13: 1030655.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancers
发表日期
2023-04
卷期
第 15 卷, 第 8 期
页码
2405
DOI
10.3390/cancers15082405
成果收录
SCIE

作者

  • H

    Huang, Liangkun (第一作者)

    wuhan univ

  • S

    Sun, Fei

    wuhan univ

查看全部 9 位作者收起作者
  • L

    Liu, Zilin

    wuhan univ

  • J

    Jin, Wenyi

  • Z

    Zhang, Yubiao

    wuhan univ

  • C

    Chen, Junwen

    wuhan univ

  • Z

    Zhong, Changheng

    wuhan univ

  • L

    Liang, Wanting

    xiamen med coll

  • P

    Peng, Hao (通讯)

    wuhan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417